211 related articles for article (PubMed ID: 25685807)
21. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.
Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY
Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146
[TBL] [Abstract][Full Text] [Related]
22. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
23. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
Halls ML; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
[TBL] [Abstract][Full Text] [Related]
24. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
25. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
[TBL] [Abstract][Full Text] [Related]
26. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
[TBL] [Abstract][Full Text] [Related]
27. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
[TBL] [Abstract][Full Text] [Related]
28. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
29. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
[TBL] [Abstract][Full Text] [Related]
30. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
[TBL] [Abstract][Full Text] [Related]
31. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Halls ML; Bathgate RA; Summers RJ
Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
[TBL] [Abstract][Full Text] [Related]
32. The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation.
Kong RC; Petrie EJ; Mohanty B; Ling J; Lee JC; Gooley PR; Bathgate RA
J Biol Chem; 2013 Sep; 288(39):28138-51. PubMed ID: 23926099
[TBL] [Abstract][Full Text] [Related]
33. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
34. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.
Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD
Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335
[TBL] [Abstract][Full Text] [Related]
35. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
36. Solid phase synthesis and structural analysis of novel A-chain dicarba analogs of human relaxin-3 (INSL7) that exhibit full biological activity.
Hossain MA; Rosengren KJ; Zhang S; Bathgate RA; Tregear GW; van Lierop BJ; Robinson AJ; Wade JD
Org Biomol Chem; 2009 Apr; 7(8):1547-53. PubMed ID: 19343240
[TBL] [Abstract][Full Text] [Related]
37. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
[TBL] [Abstract][Full Text] [Related]
38. A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.
Praveen P; Wang C; Handley TNG; Wu H; Samuel CS; Bathgate RAD; Hossain MA
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047588
[TBL] [Abstract][Full Text] [Related]
39. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
[TBL] [Abstract][Full Text] [Related]
40. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
